US Patent 7388096 Crystalline forms of a factor Xa inhibitor

Patent 7388096 was granted and assigned to Bristol-Myers Squibb on June, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

73880960

Patent Inventor Names

Xiaotian Yin0

Margaret M. Gleeson0

Mary F. Malley0

Steven R. Fabian0

Bang-Chi Chen0

Denette K. Murphy0

Gary McGeorge0

Huiping Zhang0

...

Date of Patent

June 17, 2008

Patent Application Number

112355190

Date Filed

September 26, 2005

Patent Primary Examiner

‌

Margaret D. Seaman

Patent abstract

The instant invention provides crystalline forms of 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1 (2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide and its solvates thereof; processes for the production of such crystalline forms; pharmaceutical compositions comprising such crystalline forms; and methods of treating thromboembolic disorders with such crystalline forms or such pharmaceutical compositions.